China continues to step up its probe into alleged bribery by British drugmaker GlaxoSmithKline to illegally boost sales and inflate the price of its medicines.<br /><br />Top fraud investigators have said that senior Chinese executives from the firm passed bribes to government officials, doctors, hospitals and industry associations using travel agencies as conduits for the cash. <br /><br />...<br />http://www.euronews.net/
